« Return to News | Study Conduct

Metroplex Clinical Research Center, Rheumatology Associates Open New Site

Friday, November 6, 2009 07:29 AM

Dallas-based Metroplex Clinical Research Center (MCRC) and Rheumatology Associates have opened their new 22,500-square-foot complex featuring rheumatology services and phase I-IV research services under one roof.

Founded in 1984 by rheumatologists Dr. Roy Fleischmann and Dr. Stanley Cohen, both the practice and MCRC have deep roots in North Texas.

“MCRC and Rheumatology Associates have served and have access to over 35,000 patients,” said Sara Hibbard, COO. "This arrangement provides patients of Rheumatology Associates access to cutting-edge clinical research studies.”

The facility features 22 exam rooms, infusion rooms, a full-service X-ray department, and a CLIA-certified laboratory. Within the 5,000-square-foot phase I unit are ACLS-certified critical care staff, 24-hour physician coverage, overnight accommodations for up to six patients, and recreation and lounge facilities.

The phase I unit will be expanded in 2010 to increase the inpatient capacity to 12.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.